Triple-negative breast cancer (TNBC) is one of the most heterogeneous and aggressive
breast cancer subtypes with a high risk of death on recurrence. To date, TNBC is very …

Triple-negative breast cancer (TNBC) is a subtype of poor prognosis, highly invasive and
difficult-to-treat breast cancers accounting for approximately 15% of clinical cases. Given the …

Triple-negative breast cancer (TNBC) represents a very heterogeneous group of breast
diseases. Currently, the backbone of therapy for TNBC is mainly chemotherapy as there are …

Triple-negative breast cancer (TNBC) is one of the most heterogeneous diseases in solid
tumors and has limited therapeutic options. Due to the lack of appropriate targetable …

Triple-negative breast cancer (TNBC) is a highly malignant subtype of breast cancer (BC)
with vicious behaviors. TNBC is usually associated with relatively poor clinical outcomes …

TNBC (Triple Negative Breast Cancer) is a subtype of breast cancer with an aggressive
phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic …

Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the
subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient …

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but
an effective targeted therapy has not been well-established so far. Considering the lack of …

Triple-negative breast cancer (TNBC) is the most aggressive type of cancer, with a high risk
of death on recurrence. To date, there is a lack of approved targeted agents for the treatment …

Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …